Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis
Cancer Growth and Metastasis · 2017
DOI: 10.1177/1179064417730559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Growth and Metastasis, 2017. Verfasst von Tanja Grimmig und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery I, Molecular Oncology and Immunology, University of Wuerzburg, Wuerzburg, Germany. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
In patients with peritoneal carcinomatosis cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) represents a promising treatment strategy. Here, we studied the role of hyperthermic chemotherapy on heat shock protein (HSP) expression and induction of tumor cell death and survival. HSP27, HSP70, and HSP90 combined with effects on tumor cell proliferation and chemosensitivity were analyzed in human colon cancer. Hyperthermic chemotherapy resulted in significant HSP27/HSP70 and HSP90 gene/protein overexpression in analyzed HT-29/SW480/SW620 colon cancer cells and peritoneal metastases from patients displaying amplified expression of proliferation markers, proliferating cell nuclear antigen and antiapoptotic protein Bcl-xL. Moreover, functionally increased chemoresistance against 5-fluorouracil/mitomycin C and oxaliplatin after hyperthermic chemotherapy points to induced survival mechanisms in cancer cells. In conclusion, the results indicate that intracellular HSP-associated antiapoptotic and proliferative effects after hyperthermic chemotherapy negatively influence beneficial effects of hyperthermic chemotherapy-induced cell death. Therefore, blocking HSPs could be a promising strategy to further improve the rate of tumor cell death and outcome of patients undergoing HIPEC therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery I, Molecular Oncology and Immunology, University of Wuerzburg, Wuerzburg, Germany.
- Division of Molecular Internal Medicine, Department of Internal Medicine II, University of Wuerzburg, Wuerzburg, Germany.
- Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Surgery I, University of Wuerzburg, Wuerzburg, Germany.
- Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany.
- Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Zitieren
APA
Grimmig, T., Moll, E. M., Kloos, K., Thumm, R., Moench, R., Callies, S., Kreckel, J., Vetterlein, M., Pelz, J., Polat, B., Tripathi, S., Rehder, R., Ribas, C. M., Chandraker, A., Germer, C. T., Waaga-Gasser, A. M., & Gasser, M. (2017). Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis. Cancer Growth and Metastasis. https://doi.org/10.1177/1179064417730559
Vancouver
Grimmig T, Moll EM, Kloos K, Thumm R, Moench R, Callies S, et al. Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis. Cancer Growth and Metastasis. 2017. doi:10.1177/1179064417730559
BibTeX
@article{Grimmig2017,
author = {Grimmig, Tanja and Moll, Eva-Maria and Kloos, Kerstin and Thumm, Rebecca and Moench, Romana and Callies, Simone and Kreckel, Jennifer and Vetterlein, Malte and Pelz, Joerg and Polat, Buelent and Tripathi, Sudipta and Rehder, Roberta and Ribas, Carmen M and Chandraker, Anil and Germer, Christoph-T and Waaga-Gasser, Ana Maria and Gasser, Martin},
title = {Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis},
journal = {Cancer Growth and Metastasis},
year = {2017},
doi = {10.1177/1179064417730559}
}
EUVIMED